The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance

Author: admin
Published date: 22 August 2025
Category:
Surveillance
Share

The 2017 WHO Bacterial Priority Pathogens List (BPPL) shaped global AMR policy, R&D, and investment, and since then 13 new antibiotics have been approved. The updated 2024 WHO BPPL refines this framework, ranking 24 antibiotic-resistant bacteria using multicriteria decision analysis (mortality, incidence, resistance trends, transmissibility, treatability, etc.), weighted by input from 79 international experts.

Findings:

  • Top-ranked (critical tier): carbapenem-resistant Klebsiella pneumoniae (84%), carbapenem-resistant Acinetobacter spp., 3rd-generation cephalosporin-resistant Escherichia coli, and rifampicin-resistant Mycobacterium tuberculosis.

  • High community burden: fluoroquinolone-resistant Salmonella Typhi (72%), Shigella spp. (70%), and Neisseria gonorrhoeae (64%).

  • Other important pathogens include Pseudomonas aeruginosa and Staphylococcus aureus.

  • Rankings were highly consistent across expert groups (Spearman’s ρ = 0.9).

Interpretation:
The 2024 BPPL confirms Gram-negative bacteria and rifampicin-resistant TB as critical threats, while also emphasising community-associated pathogens. It is designed to steer R&D, global policy, and investment toward new antibacterials, but also highlights the need for equitable drug access, stronger vaccine coverage, and robust infection prevention and control measures.

Stay Updated

Stay connected to keep up with the latest on antimicrobial resistance.

Name(Required)